Browsing by Sponsor/Funder Action Against Cancer

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 8 to 17 of 17 < previous 
Issue DateTitleAuthor(s)
Oct-2018MicroRNAs as bile-based biomarkers for pancreatic and biliary-tract cancersFrampton, Adam; Krell, Jonathan; Stebbing, Justin; Mato Prado, Mireia;
10-Feb-2016miR-515-5p controls cancer cell migration through MARK4 regulationPardo, OE; Munro, CE; Castellano, L; Hu, Y; Mauri, F, et al
1-Jan-2017Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high CTC countsShaw, JA; Guttery, DS; Hills, A; Fernandez-Garcia, D; Page, K, et al
6-Sep-2016Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancerDalgleish, AG; Stebbing, J; Adamson, DJA; Arif, SS; Bidoli, P, et al
Feb-2021SCIRT lncRNA restrains tumorigenesis by opposing transcriptional programs of tumor-initiating cells.Zagorac, S; De Giorgio, A; Dabrowska, A; Kalisz, M; Casas-Vila, N, et al
15-Jun-2019SSB1/SSB2 proteins safeguard B-cell development by protecting the genomes of B-cell precursorsPfeifer, M; Brem, R; Lippert, T; Boulianne, B; Ho, HN, et al
25-Jan-2017Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFRCastellano, L; Dabrowska, A; Pellegrino, L; Ottaviani, S; Cathcart, P, et al
10-May-2018TGF-ß induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progressionOttaviani, S; Stebbing, J; Frampton, A; Zagorac, S; Krell, J, et al
16-Jan-2018The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomasCarter, P; Alifrangis, CC; Chandrasinghe, P; Cereser, B; Del Bel Belluz, L, et al
17-Jan-2012The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancyPayne, RE; Hava, NL; Page, K; Blighe, K; Ward, B, et al